These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3899780)

  • 1. Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process.
    Pay TW; Boge A; Menard FJ; Radlett PJ
    Dev Biol Stand; 1985; 60():171-4. PubMed ID: 3899780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel process for the production of a veterinary rabies vaccine in BHK-21 cells grown on microcarriers in a 20-l bioreactor.
    Kallel H; Rourou S; Majoul S; Loukil H
    Appl Microbiol Biotechnol; 2003 Jun; 61(5-6):441-6. PubMed ID: 12764557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The present status of rabies vaccine development and clinical experience with rabies vaccine.
    Roumiantzeff M
    Southeast Asian J Trop Med Public Health; 1988 Dec; 19(4):549-61. PubMed ID: 3070767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of an inactivated rabies vaccine in primary dog kidney cells.
    van Wezel AL; van Steenis G
    Dev Biol Stand; 1978; 40():69-75. PubMed ID: 98375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale concentration and purification of virus suspension from microcarrier culture for the preparation of inactivated virus vaccines.
    van Wezel AL; van Herwaarden JA; van de Heuvel-de Rijk EW
    Dev Biol Stand; 1979; 42():65-9. PubMed ID: 223923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rabies vaccine produced in a non-tumorigenic rabbit cell line.
    Sureau P; Perrin P; Horaud F
    Dev Biol Stand; 1985; 60():133-9. PubMed ID: 4043531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative determination of rabies antigen by ELISA.
    van der Marel P; van Wezel AL
    Dev Biol Stand; 1981; 50():267-75. PubMed ID: 7341294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines.
    van Wezel AL; van Steenis G; Hannik CA; Cohen H
    Dev Biol Stand; 1978; 41():159-68. PubMed ID: 223908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans.
    Lalosević D; Lalosević V; Lazarević-Ivanc Lj; Knezević I
    Dev Biol (Basel); 2008; 131():421-9. PubMed ID: 18634504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purified chick embryo cell (PCEC) rabies vaccine for human use. Laboratory data.
    Barth R; Gruschkau H; Jaeger O; Milcke L; Weinmann E
    Behring Inst Mitt; 1984 Nov; (76):142-54. PubMed ID: 6525146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivated rabies vaccine produced from the Flury LEP strain of virus grown in BHK-21 suspension cells.
    Chapman WG; Ramshaw IA; Crick J
    Appl Microbiol; 1973 Dec; 26(6):858-62. PubMed ID: 4588193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of BHK suspension cells for the commercial production of foot and mouth disease vaccines over a twenty year period.
    Radlett PJ; Pay TW; Garland AJ
    Dev Biol Stand; 1985; 60():163-70. PubMed ID: 2995169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
    Koprowski H
    Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical trial of YU BHK Rabivak vaccine against rabies in volunteers].
    Lalosević V; Lazarević-Ivanc L; Lalosević D
    Med Pregl; 2001; 54 Suppl 1():23-7. PubMed ID: 12078123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of antigen-specific antibody response in human peripheral blood lymphocytes in vitro by a dog kidney cell vaccine against rabies virus (DKCV).
    Uytdehaag FG; Osterhaus AD; Loggen HG; Bakker RH; van Asten JA; Kreeftenberg JG; van der Marel P; van Steenis B
    J Immunol; 1983 Sep; 131(3):1234-9. PubMed ID: 6193180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and efficacy of an in-house developed cell-culture derived veterinarian rabies vaccine.
    Kallel H; Diouani MF; Loukil H; Trabelsi K; Snoussi MA; Majoul S; Rourou S; Dellagi K
    Vaccine; 2006 May; 24(22):4856-62. PubMed ID: 16600442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabies veterinary virus vaccine produced in BHK-21 cells grown on microcarriers in a bioreactor.
    Gallegos Gallegos RM; Espinosa Larios EL; Ramos Ramírez L; Kretschmer Schmid R; Aguilar Setién A
    Arch Med Res; 1995; 26(1):59-63. PubMed ID: 7711449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system.
    Perrin P; Madhusudana S; Gontier-Jallet C; Petres S; Tordo N; Merten OW
    Vaccine; 1995 Sep; 13(13):1244-50. PubMed ID: 8578811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabies vaccine prepared from the virus grown in Japanese quail embryo cell cultures.
    Bektemirova MS; Pille ER; Matevosyan KS; Nagieva FG
    Acta Virol; 1983 Jan; 27(1):59-64. PubMed ID: 6133431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3).
    Shen CF; Lanthier S; Jacob D; Montes J; Beath A; Beresford A; Kamen A
    Vaccine; 2012 Jan; 30(2):300-6. PubMed ID: 22079076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.